Published in Blood on May 01, 1996
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood (2009) 2.73
Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood (2005) 2.04
Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk. Cancer Cell (2011) 1.44
Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol (2008) 1.35
Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biol Blood Marrow Transplant (2010) 1.33
Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. J Clin Oncol (2009) 1.29
Therapy-related myelodysplasia and acute myeloid leukemia. Semin Oncol (2013) 1.15
Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol Blood Marrow Transplant (2014) 1.15
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood (2014) 1.14
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol (2013) 1.13
The role of EBV in post-transplant malignancies: a review. J Clin Pathol (2000) 1.02
Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia (2010) 0.97
Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant (2011) 0.96
Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation. Br J Haematol (2013) 0.96
Post-transplant lymphoproliferative disorder localized in the colon after liver transplantation: report of a case. Surg Today (2009) 0.95
Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up. Expert Rev Hematol (2011) 0.93
Solid tumor second primary neoplasms: who is at risk, what can we do? Semin Oncol (2013) 0.92
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep (2013) 0.89
Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review. Med Oncol (2009) 0.88
Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors. Cancer Epidemiol Biomarkers Prev (2011) 0.87
Subsequent malignant neoplasms after hematopoietic cell transplantation. Biol Blood Marrow Transplant (2012) 0.87
Oral carcinoma after hematopoietic stem cell transplantation--a new classification based on a literature review over 30 years. Head Neck Oncol (2009) 0.86
Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors. Cancer (2014) 0.85
NMR-based metabolomic analysis of the molecular pathogenesis of therapy-related myelodysplasia/acute myeloid leukemia. J Proteome Res (2011) 0.84
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study. Lancet Oncol (2016) 0.83
Total lymphoid irradiation based conditioning for hematopoietic stem cell transplantation in severe aplastic anemia. Radiat Oncol J (2012) 0.81
Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant (2012) 0.79
Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients. Cancer Biol Ther (2013) 0.78
Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys (2012) 0.78
Plasmablastic lymphoma following transplantation. Proc (Bayl Univ Med Cent) (2013) 0.77
Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy. Leukemia (2014) 0.76
Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT. Bone Marrow Transplant (2015) 0.76
Childhood to adult transition and long-term follow-up after blood and marrow transplantation. Bone Marrow Transplant (2015) 0.76
Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes. PLoS One (2017) 0.75
Bronchial mucoepidermoid carcinoma after allogeneic bone marrow transplantation. J Clin Pathol (1997) 0.75
Eleven secondary cancers after hematopoietic stem cell transplantation using a total body irradiation-based regimen in 370 consecutive pediatric and adult patients. Springerplus (2013) 0.75
Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood. Children (Basel) (2015) 0.75
Unveiling Cancer. Sultan Qaboos Univ Med J (2015) 0.75
Purification and mapping of specific mRNAs by hybridization-selection and cell-free translation. Proc Natl Acad Sci U S A (1979) 9.94
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med (1999) 9.02
Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med (1997) 6.72
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med (1989) 6.66
The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys (1969) 6.55
Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest (2000) 5.88
Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med (1996) 5.14
Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst (2001) 4.69
Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol (2001) 4.56
An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int (2001) 2.94
A population-based study of the usefulness of screening for neuroblastoma. Lancet (1997) 2.92
Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer (1995) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med (1987) 2.59
E1a regions of the human adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related. J Virol (1985) 2.59
Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. Cancer Res (1989) 2.55
Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (1995) 2.40
Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol (1997) 2.36
Association between childhood acute lymphoblastic leukemia and use of electrical appliances during pregnancy and childhood. Epidemiology (1998) 2.33
Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med (1991) 2.27
Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer (1993) 2.19
The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore) (1993) 2.18
National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health (1997) 2.17
Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant (2011) 1.96
Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med (1980) 1.95
Methods utilizing cell-free protein-synthesizing systems for the identification of recombinant DNA molecules. Methods Enzymol (1983) 1.94
Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol (1997) 1.87
Pneumatosis intestinalis after bone marrow transplantation. AJR Am J Roentgenol (1988) 1.85
Prone positioning attenuates and redistributes ventilator-induced lung injury in dogs. Crit Care Med (2000) 1.83
Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion. Clin Chem (1989) 1.83
Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia? Am J Epidemiol (2000) 1.82
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant (2011) 1.82
Influence of prone position on the extent and distribution of lung injury in a high tidal volume oleic acid model of acute respiratory distress syndrome. Crit Care Med (1997) 1.82
Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health (2001) 1.80
Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res (1991) 1.77
Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer Group. Leukemia (1994) 1.76
Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA (1994) 1.76
Passive smoking: a review of medical and legal issues. Am J Public Health (1989) 1.75
Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant (2000) 1.75
Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood (1994) 1.75
New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplant (2008) 1.70
Trends in cancer incidence among children in the U.S. Cancer (1996) 1.69
Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr (1998) 1.65
Postoperative pain control after lumbar spine fusion. Patient-controlled analgesia versus continuous epidural analgesia. Spine (Phila Pa 1976) (1997) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant (2000) 1.64
Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project. Pediatrics (1990) 1.64
Fragility fractures of the hip and femur: incidence and patient characteristics. Osteoporos Int (2009) 1.63
Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med (2001) 1.63
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant (2006) 1.63
Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev (1994) 1.63
Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med (1994) 1.58
Renal aspergilloma: an unusual cause of infection in a patient with the acquired immunodeficiency syndrome. Am J Med (1992) 1.56
Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer (1996) 1.56
Abdominal compartment syndrome after mesenteric revascularization. J Vasc Surg (2001) 1.56
Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer (1991) 1.53
Arrangement of messenger RNAs and protein coding sequences in the major late transcription unit of adenovirus 2. J Mol Biol (1980) 1.53
Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. Int J Radiat Oncol Biol Phys (1995) 1.53
Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. Am J Med (2001) 1.51
Seasonal variations in the diagnosis of childhood cancer in the United States. Br J Cancer (1999) 1.50
In vivo diode dosimetry for routine quality assurance in IMRT. Med Phys (2003) 1.49
Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg (1991) 1.47
Residential pesticide exposure and neuroblastoma. Epidemiology (2001) 1.47
Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med (1992) 1.47
Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu. Exp Hematol (1999) 1.47
Control selection using random digit dialing for cases of childhood cancer. Am J Epidemiol (1984) 1.46
Molecular alteration of alpha-2-macroglobulin by aliphatic amines. Biochim Biophys Acta (1968) 1.46
Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol (2000) 1.45
A room-temperature molecular/organic-based magnet. Science (1991) 1.44
Sensitivity to proteolytic enzymes in laundry detergents. J Allergy (1971) 1.44
Treatment of acquired severe aplastic anemia. Am J Pediatr Hematol Oncol (1989) 1.44
Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation. N Engl J Med (1984) 1.43
Liquid pasteurization of an immunoglobulin preparation without stabilizer: effects on its biological and biochemical properties. Vox Sang (1996) 1.42
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol (1995) 1.42
Bone marrow transplantation for Fanconi anemia. Blood (1995) 1.42
Late graft rejection and second infusion of bone marrow in children with aplastic anaemia. Br J Haematol (1999) 1.42
Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst (1994) 1.41
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant (1999) 1.41
Weak ferromagnetism in a three-dimensional manganese(II) azido complex, [Mn(4,4'-bipy)(N3)2]n (bipy = bipyridine). Inorg Chem (2000) 1.40
In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts. Blood (1989) 1.40
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment. Am J Med (1988) 1.39
Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells. Blood (1998) 1.39
Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genet (1993) 1.38
Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood (1990) 1.38
Individual adenovirus type 5 early region 1A gene products elicit distinct alterations of cellular morphology and gene expression. J Virol (1985) 1.38